Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer

Autor:	Caroline van Dijck – van Boetzelaer, Midas B. Mulder, Gert-Jan M van de Geijn, Paul Hamberg, Elsbeth M. Westerman, Erwin Birnie, Egbert R. Boevé
Přispěvatelé:	Health Psychology Research (HPR)
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Male Oncology medicine.medical_specialty CASTRATION Antineoplastic Agents Hormonal CARCINOMA medicine.drug_class 030218 nuclear medicine & medical imaging law.invention Androgen deprivation therapy NORMALIZATION 03 medical and health sciences Prostate cancer chemistry.chemical_compound INTERMITTENT 0302 clinical medicine Randomized controlled trial law Internal medicine Carcinoma Humans Medicine Testosterone Radiology Nuclear Medicine and imaging KINETICS SUPPRESSION business.industry Prostatic Neoplasms Cancer Androgen Antagonists Hematology General Medicine Prostate-Specific Antigen medicine.disease ESTROGEN Castration chemistry Estrogen SERUM TESTOSTERONE 030220 oncology & carcinogenesis Androgens business
Zdroj:	ACTA ONCOLOGICA, 60(4), 539-543. Taylor & Francis Ltd
ISSN:	0284-186X
Popis:	Prostate cancer is the most common form of cancer in Dutch men [1]. Chemical or surgical castration is a key strategy in patients with locally advanced or metastatic prostate cancer [2]. Currently,...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84da0699a811cd2074aeef99ef97a4b https://hdl.handle.net/11370/cf125cbb-809a-4177-bc2a-0702f5d3c5bc Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.